Rialto Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Rialto Wealth Management's PFE Position: Q3 2026 in Review
Rialto Wealth Management increased its Pfizer (PFE) stake by 9.5% in Q3 2026, buying an estimated $3.35K and bringing the position to 1,457 shares worth $41.6K. The position accounts for 0.01% of the portfolio, ranked #347.
Rialto Wealth Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Rialto Wealth Management held 1,457 shares of Pfizer worth $41.6K as of Q3 2026.
- Rialto Wealth Management bought 126 Pfizer shares in Q3 2026, an estimated $3.35K.
- Pfizer made up 0.01% of Rialto Wealth Management's portfolio in Q3 2026, its #347 holding.
- Rialto Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.